A carregar...
Long‐Term safety of pravastatin‐gemfibrozil therapy in mixed hyperlipidemia
Background: Combined HMG‐CoA reductase inhibitor and fibric acid derivative therapy is often necessary for the effective reduction of concentrations of low‐density lipoprotein (LDL) cholesterol and triglycerides in patients with mixed hyperlipidemia; however, the potential risk of myopathy has limit...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6655916/ https://ncbi.nlm.nih.gov/pubmed/9929751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960220110 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|